NODAT Risk Similar After Switching from CNIs to Everolimus
The incidence of NODAT was 33.8% among patients who switched to everolimus and 36.4% among those who stayed on calcineurin inhibitors.
Sitio Web patrocinado por:
Sitio Web patrocinado por:
The incidence of NODAT was 33.8% among patients who switched to everolimus and 36.4% among those who stayed on calcineurin inhibitors.
Copyright © 2025, Sociedad Venezolana de Nefrología - RIF: J-30370247-3.
Diseñado por 